Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17923947 | 0.79 | LPAR2 (0.34) | LPAR2LPAR3 | |
| SCHEMBL17923946 | 0.70 | — | — | |
| SCHEMBL3360558 | 0.68 | LPAR2 (0.32) | LPAR2LPAR3 | |
| SCHEMBL27657673 | 0.68 | — | — | |
| SCHEMBL11316152 | 0.68 | LPAR2 (0.32) | LPAR2LPAR3 | |
| SCHEMBL27746010 | 0.68 | TDP1 (0.39) | — | |
| SCHEMBL4819596 | 0.67 | LMNA (0.38) | — | |
| SCHEMBL6525269 | 0.67 | LMNA (0.38) | — | |
| SCHEMBL29053654 | 0.66 | LPAR2 (0.36) | LPAR2LPAR3 | |
| SCHEMBL6420646 | 0.66 | ALDH1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11882836-B2 | 1-amino-1-cyclopropanecarboxylic acid mixtures and uses thereof | VALENT BIOSCIENCES LLC (US) | 2024-01-30 | — | — | US | disclosed |
| US-11317626-B2 | Forchlorfenuron mixtures and uses thereof | VALENT BIOSCIENCES LLC (US) | 2022-05-03 | — | — | US | disclosed |
| US-20210400978-A1 | 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID MIXTURES AND USES THEREOF | VALENT BIOSCIENCES LLC (US) | 2021-12-30 | — | — | US | disclosed |
| EP-3755679-A1 | FORCHLORFENURON MIXTURES AND USES THEREOF | Valent BioSciences LLC (US) | 2020-12-30 | — | — | EP | disclosed |
| WO-2019165172-A1 | FORCHLORFENURON MIXTURES AND USES THEREOF | VALENT BIOSCIENCES LLC (US) | 2019-08-29 | — | — | WO | disclosed |
| US-20190261629-A1 | FORCHLORFENURON MIXTURES AND USES THEREOF | VALENT BIOSCIENCES LLC | 2019-08-29 | — | — | US | disclosed |
| US-9561160-B2 | Oral care composition and processes for preparing same | COLGATE-PALMOLIVE COMPANY (US) | 2017-02-07 | — | — | US | disclosed |
| US-20160038385-A1 | Oral Care Composition and Processes for Preparing Same | COLGATE-PALMOLIVE COMPANY (US) | 2016-02-11 | — | — | US | disclosed |
| WO-2014143017-A1 | ORAL CARE COMPOSITION AND PROCESSES FOR PREPARING SAME | COLGATE-PALMOLIVE COMPANY (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20120288547-A1 | STABILIZATION OF ZINC OXIDE FILM IN ORAL COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2012-11-15 | — | — | US | disclosed |
| US-5833956-A | Oral composition containing an anionic, a nonionic and an amphoteric surfactant system | COLGATE-PALMOLIVE COMPANY (US) | 1998-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120288547-A1 | STABILIZATION OF ZINC OXIDE FILM IN ORAL COMPOSITIONS | SLC39A7, SOD1, SLC30A7 | LPAR2 4348/4885LPAR3 4414/4885 |
| US-11882836-B2 | 1-amino-1-cyclopropanecarboxylic acid mixtures and uses thereof | BMP1, ACACA, AHCY | LPAR2 2779/4885LPAR3 2595/4885 |
| US-20210400978-A1 | 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID MIXTURES AND USES THEREOF | ACACA, PCCA, MCCC2 | LPAR2 1779/4885LPAR3 1691/4885 |
| US-20190261629-A1 | FORCHLORFENURON MIXTURES AND USES THEREOF | BROX, CNPY3, CNPY2 | LPAR2 1445/4885LPAR3 302/4885 |
| US-11317626-B2 | Forchlorfenuron mixtures and uses thereof | BROX, CNPY3, CNPY2 | LPAR2 1445/4885LPAR3 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.